All pre-existing resistant starch research focused on supplementation at large doses (>30g), which presented inclusion obstacles into most product formulations.

To solve this, we wanted to prove that lower RS2 doses were also effective at supporting gut microbiome health. We contracted Nutrasource, a leading Canadian research facility, to conduct the study and compile quality human data.

The results confirmed our hypothesis, and so much more!

This study has opened the door to various new RS2 product formulation possibilities and label claims that could span a brand’s entire product portfolio.